Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma

This study has been completed.
Brigham and Women's Hospital
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Information provided by:
Dana-Farber Cancer Institute Identifier:
First received: September 14, 2005
Last updated: April 27, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2005
  Primary Completion Date: August 2005 (Final data collection date for primary outcome measure)